
MedImmune buys AlphaCore for early-stage cholesterol project
Executive Summary
AstraZeneca PLC’s MedImmune LLC division has acquired private cardiovascular drug developer AlphaCore Pharma.
Deal Industry
- Pharmaceuticals
-
Biotechnology
- Large Molecule
Deal Status
- Final
Deal Type
-
Acquisition
- Acquisition of Private Biotech
- Full Acquisition
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com